Literature DB >> 20122921

A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice.

Ulrike Böer1, Christine Noll, Irmgard Cierny, Doris Krause, Christoph Hiemke, Willhart Knepel.   

Abstract

The transcription factor CREB regulates adaptive responses like memory consolidation, addiction, and synaptic refinement. Recently, chronic psychosocial stress as animal model of depression has been shown to stimulate CREB transcriptional activity in the brain; this stimulation was prevented by treatment with the antidepressant imipramine, which inhibits both noradrenaline and serotonin reuptake. However, it was unknown whether the selective inhibition of serotonin reuptake is sufficient for inhibition of stress-induced CREB activation, as it is for the clinical antidepressant effect. Therefore, the effect of two selective serotonin reuptake inhibitors (SSRIs), citalopram and fluoxetine, was examined in this study. Transgenic CRE-luciferase reporter gene mice were used to monitor gene transcription directed by the CREB DNA binding site (CRE) in vivo. Chronic psychosocial stress for 25days stimulated CRE/CREB-directed luciferase expression in the hippocampus and other brain regions. When applied alone to non-stressed mice, citalopram caused a transient increase after 24h that was lost after 21days of treatment, whereas fluoxetine had no effect after 24h and produced an inhibition in the pons and hypothalamus after 21days of treatment. However, both citalopram and fluoxetine treatment completely abolished the increase in CRE/CREB-directed transcription induced by chronic psychosocial stress. As indicated by Western blots, the changes in CRE/CREB-directed transcription were accompanied by corresponding changes in the phosphorylation of CREB at serine-119. These results further emphasize the role of CREB in stress-induced gene expression and suggest furthermore that inhibition of stress-induced CREB activity may be a common mechanism of action of SSRIs underlying their antidepressive effect. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122921     DOI: 10.1016/j.ejphar.2010.01.016

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 2.  Utility of genetically modified mice for understanding the neurobiology of substance use disorders.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

3.  Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus.

Authors:  Carolina Araya-Callís; Christoph Hiemke; Nashat Abumaria; Gabriele Flugge
Journal:  Psychopharmacology (Berl)       Date:  2012-05-18       Impact factor: 4.530

4.  Pharmacogenetics of antidepressants.

Authors:  Concetta Crisafulli; Chiara Fabbri; Stefano Porcelli; Antonio Drago; Edoardo Spina; Diana De Ronchi; Alessandro Serretti
Journal:  Front Pharmacol       Date:  2011-02-16       Impact factor: 5.810

Review 5.  The Antidepressant-like Effects of Estrogen-mediated Ghrelin.

Authors:  Pu Wang; Changhong Liu; Lei Liu; Xingyi Zhang; Bingzhong Ren; Bingjin Li
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

6.  Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test.

Authors:  Katarzyna Rafa-Zabłocka; Grzegorz Kreiner; Monika Bagińska; Justyna Kuśmierczyk; Rosanna Parlato; Irena Nalepa
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.